Liraglutide versus colesevelam for treating bile acid diarrhoea

被引：0
|
作者：
Zhang, Fei [1 ]
Ge, Chunlin [1 ]
机构：
[1] China Med Univ, Dept Hepatobiliary & Pancreat Surg, Hunnan Div, Hosp 1, Shenyang 11001, Peoples R China
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2022年 / 7卷 / 12期
关键词：
OUTCOMES;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1075 / 1075
页数：1
相关论文
共 50 条
  • [1] Treating bile acid diarrhoea with liraglutide
    Walters, Julian R. F.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (10): : 897 - 899
  • [2] Lessons from a trial of colesevelam for bile acid diarrhoea
    Walters, Julian
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (04): : 290 - 291
  • [3] The analysis of gut microbiota in patients with bile acid diarrhoea treated with colesevelam
    Kumar, Aditi
    Quraishi, Mohammed Nabil
    Al-Hassi, Hafid O.
    El-Asrag, Mohammed E.
    Segal, Jonathan P.
    Jain, Manushri
    Steed, Helen
    Butterworth, Jeffrey
    Farmer, Adam
    Mclaughlin, John
    Beggs, Andrew
    Brookes, Matthew J.
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [4] Colesevelam is effective and well-tolerated for bile acid diarrhoea in Australia
    Monitto, Cassandra
    Swaminathan, Akhilesh
    Van Wees, Jacoba
    Coutsouvelis, John
    Boussioutas, Alex
    Sparrow, Miles P.
    Dooley, Michael
    Ward, Mark
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 235 - 236
  • [5] Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial
    Karhus, Martin L.
    Bronden, Andreas
    Forman, Julie L.
    Haaber, Anne
    Knudsen, Elisabeth
    Langholz, Ebbe
    Dragsted, Lars O.
    Hansen, Svend H.
    Krakauer, Martin
    Vilsboll, Tina
    Sonne, David P.
    Knop, Filip K.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (10): : 922 - 931
  • [6] Colesevelam - a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia
    Esan, Oluwayemisi
    Viljoen, Adie
    Wierzbicki, Anthony S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (12) : 1363 - 1370
  • [7] Liraglutide and Colesevelam Change Serum and Fecal Bile Acid Levels in a Randomized Trial With Patients With Bile Acid Diarrhea
    Ellegaard, Anne-Marie
    Karhus, Martin L.
    Krych, Lukasz
    Sonne, David P.
    Forman, Julie L.
    Hansen, Svend H.
    Dragsted, Lars Ove
    Nielsen, Dennis S.
    Knop, Filip K.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2024, 15 (11)
  • [8] Colesevelam: an improved bile acid sequestrant for treating hypercholesterolemia and improving diabetes
    Viljoen, Adie
    Wierzbicki, Anthony S.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (06) : 825 - 834
  • [9] Editorial: colesevelam effects on faecal bile acids in IBS with diarrhoea
    Walters, J. R. F.
    Appleby, R. N.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (07) : 696 - 697
  • [10] TREATMENT WITH THE BILE-ACID SEQUESTRANT COLESEVELAM IMPROVES LENALIDOMIDE ASSOCIATED DIARRHOEA IN MYELOMA PATIENTS
    Pawlyn, C.
    Khan, M. S.
    Davies, F. E.
    Sriskandarajah, P.
    Kaiser, M.
    Andreyev, J.
    Morgan, G. J.
    HAEMATOLOGICA, 2014, 99 : 382 - 382
12345